SGI said this week that the Translational Research Institute, an Australian medical research and biopharmaceutical facility, has selected one of SGI's high-performance computing solutions to support its biomedical research efforts.
According to SGI, TRI's new hardware provides more than 2,200 rackable compute cores, 256 cores and 4 terabytes of memory, and more than one petabyte of storage. Researchers will also be able to store and access up to 3 petabytes of historical and inactive data using SGI's DMF system.
The compute infrastructure will support efforts at TRI to study diseases such as cancer, diabetes, inflammatory diseases, HIV, malaria, bone and joint diseases, and obesity.
The financial details of the purchase were not disclosed.